Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 2012. The document serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons, rather than a comprehensive financial report.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The only financial figure disclosed is the share price of 1467.31 pence per share at the time of a specific transaction.
Material Changes
No material changes to the company's financial position or operations are reported in this document. The filing details a specific increase in shareholding by a connected person.
Management Commentary and Risks
There is no management commentary, guidance, outlook, or discussion of risks and contingencies in this filing. The document strictly reports a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(c).
Key Facts for Investors
- Transaction Type: Increase in ordinary shares via dividend re-investment.
- Connected Person: Mrs K Thomson (connected to Director Mr P C Thomson).
- Shares Acquired: 35,214 ordinary shares.
- Transaction Price: 1467.31 pence per share.
- Transaction Date: April 19, 2012.
- Dividend Date: April 12, 2012.